Published in:

02-09-2022 | General Anesthesia | Correction

Correction: Intrapandemic regional anesthesia as practice: a historical cohort study in patients undergoing breast cancer surgery

Authors: Ariane Clairoux, MD, FRCPC, Maxim Soucy-Proulx, MD, François Pretto, MD, Victoria Courgeon, MD, Maxime Caron-Goudreau, MD, Rami Issa, MD, Beng, FRCPC, Marie-Ève Bélanger, MD, PGdip(ed), FRCPC, Véronique Brulotte, MD, MSc, FRCPC, Olivier Verdonck, MD, MSc, DESAR, Moulay Idrissi, BEng, MSc, Annik Fortier, MSc, Philippe Richebé, MD, PhD, DESAR

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 11/2022

Excerpt

In Table 2, column “Intrapandemic group,” the denominators have been corrected to reflect patients who received general anesthesia vs regional anesthesia and sedation (n = 24 and n = 80, respectively)

Table 2

Intraoperative data

Outcome	Prepandemic group N = 106	Intrapandemic group N = 104	Absolute difference (95% CI)	P value
General anesthesia:			77% (69 to 85)	< 0.001^a
Yes	106/106 (100%)	24/104 (23%)
No	0/106 (0%)	80/104 (77%)
General anesthesia:				< 0.001^a
Paravertebral block	0/106 (0%)	5/24^b (21%)	-21% (-37 to -5)
PEC2 block	34/106 (32%)	11/24^b (46%)	-14% (-36 to 8)
Serratus block	1/106 (1%)	5/24^b (21%)	-20% (-36 to -4)
ESP block	1/106 (1%)	1/24^b (4%)	-3% (-11 to 5)
Without block	70/106 (66%)	2/24^b (8%)	58% (43 to 72)
Regional anesthesia and sedation:				NA
Paravertebral block		78/80^c (98%)
ESP block		1/80^c (1%)
Epidural		1/80^c (1%)
TIVA	2/106 (2%)	0/24^b (0%)	2% (-14 to 7)	1.00^d
Volatile	104/106 (98%)	24/24^b (100%)	-2% (-7 to 14)	1.00^d
Block failure		3/80^c (4%)		NA
Total intraoperative fentanyl (µg)	121 [99–200]	50 [0–150]	50 (36 to 78)	< 0.001^e
Number of intraoperatively administered PONV prophylaxis medications^f				< 0.001^a
0	4/106 (4%)	16/104 (15%)	-12% (-19 to -4)
1	11/106 (10%)	43/104 (41%)	-31% (-42 to -20)
2	63/106 (59%)	32/104 (31%)	29% (16 to 42)
3	28/106 (26%)	13/104 (13%)	14% (3 to 24)
PONV prophylaxis with 2 or more treatments	91/106 (86%)	45/104 (43%)	43% (31 to 54)	< 0.001^a

All numbers are represented as median [interquartile range] or as n/total N (%); differences are (prepandemic – intrapandemic)

^aChi square test, difference in percentages (95% CI)

^bThe denominator reflects those patients on the intrapandemic group who received general anesthesia

^cThe denominator reflects those patients on the intrapandemic group who received regional anesthesia and sedation

^dFisher’s exact test, difference in percentages (exact 95% CI)

^eMann–Whitney–Wilcoxon test, difference in medians (95% CI) [estimated using the Hodges–Lehmann method]

^fDexamethasone, haloperidol, ondansetron, or aprepitant

CI = confidence interval; ESP = erector spinae plane; PEC2 = plane block between pectoralis minor and serratus anterior; PONV = postoperative nausea and vomiting; TIVA = total intravenous anesthesia

…

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Correction: Intrapandemic regional anesthesia as practice: a historical cohort study in patients undergoing breast cancer surgery

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2022

In reply: Withholding therapeutic interventions in brain(stem) death: is it a self-fulfilling prophecy?

Can we trust radial artery pressure monitoring for cardiac surgery?

Association of body fluid distribution with obstructive sleep apnea in pregnant individuals with a body mass index ≥ 40 kg·m2—a prospective observational feasibility study

Efficacy and safety of intranasal ketamine compared with intranasal dexmedetomidine as a premedication before general anesthesia in pediatric patients: a systematic review and meta-analysis of randomized controlled trials

Postoperative hypotonia in a patient with stiff person syndrome: a case report and literature review

Development of local guidelines to prevent perioperative hypothermia in children: a prospective observational cohort study